| Literature DB >> 23181158 |
Dominik Freche1, Chun-Yao Lee, Nathalie Rouach, David Holcman.
Abstract
Synaptic transmission depends on several molecular and geometric components, such as the location of vesicular release, the number of released neurotransmitter molecules, the number and type of receptors, as well as the synapse organization. Our goal here is to illustrate how synaptic modeling allows extracting quantitative information in the context of neurological diseases and associated therapies. Combining electrophysiology with simulation tools, we first evaluate the reduction in synaptically released glutamate molecules induced by a ketogenic diet. In a second part, because the scaffolding molecule Shank3 is disrupted at the postsynaptic density in Autism Spectral Disorders, we present a numerical simulation of the synaptic response where this disruption leads to an alteration of the excitatory AMPA receptor trafficking. The take home message is that combining recent experimental findings with modeling approaches allows obtaining precise quantitative properties of what was still unapproachable a decade ago.Entities:
Keywords: Shank3 mutation; autism; brownian simulations; glutamate dynamics; ketogenic diet; modeling; synaptic transmission
Year: 2012 PMID: 23181158 PMCID: PMC3502205 DOI: 10.4161/cib.20818
Source DB: PubMed Journal: Commun Integr Biol ISSN: 1942-0889

Figure 1. Quantifying the effect of ketone bodies on synaptic transmission. Ketone bodies decrease basal synaptic transmission of CA1 pyramidal cells: depression of fEPSPs in (A) β-hydroxybutyrate (βHB, 11 mM) (p < 0.001, n = 8) and (B) acetoacetate (ACA, 11 mM) (p < 0.001, n = 8). Sample traces of averaged field potentials before (trace 1) and during (trace 2) ketone bodies application, as indicated by the numbers, are shown below the curves (A, B). Scale bar, 0.2 mV, 10 ms. (C) Graph summarizing the peak depressions of fEPSPs during perfusion of βHB or ACA for 30 min. (D) Schematic representation of the synapse for the simulation. (E) Brownian dynamics simulation of synaptic current response in normal (green) and after glutamate reduction (red). A small variation of the vesicular release in the active zone has little effect (dotted red). (F) Effect of increasing the number of AMPARs, necessary to compensate for the reduction in the number of released glutamate molecules.
Table 1. Simulation parameters for the synaptic current
| Total length of the pre-/postsynaptic cylinders | 1 µm |
| Cleft height | 20 nm |
| Distance of the glial sheath from the synaptic cylinder surfaces | 40 nm |
| PSD diameter | 300 nm |
| Cleft diameter | 800 nm |
| Vesicle content (glutamate molecules) | 3 000 |
| Glutamate diffusion constant | 0.2 µm2/ms |
| AMPARs on the PSD | 50 |
| AMPARs in the intra-cleft reservoir | 31 |
| Transporter densities on the glial sheath | 5 000 µm−2 |
| Time step size Δt | 5 × 10 −4 ms |

Figure 2. Quantifying the effect of Shank3-like mutation on synaptic transmission. (A) Schematic representation of the synapse with neuroligin and Shank3 disruption. (B) Synaptic response in normal (green) and Shank3-like mutation (blue) upon spreading the vesicle release sites, distributed as in a wild type synapse (solid blue) and over the pre-synaptic terminal (dotted). AMPARs are uniformly distributed over the postsynaptic terminal (blue) and vesicles are distributed over the presynaptic terminal (dashed blue).